Skip to main content
SpringerLink
Log in

Age-Related Changes in Cobalamin (Vitamin B12) Handling

Implications for Therapy

  • Review Article
  • Physiological Aspects of Aging
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Cobalamin (vitamin B12) deficiency is more common in the elderly than in younger patients. This is because of the increased prevalence of cobalamin malabsorption in this age group, which is mainly caused by (autoimmune) atrophic body gastritis. Cobalamin supplementation is affordable and nontoxic, and it may prevent irreversible neurological damage if started early. Elderly individuals with cobalamin deficiency may present with neuropsychiatric or metabolic deficiencies, without frank macrocytic anaemia. An investigation of symptoms and/or signs includes the diagnosis of deficiency as well as any underlying cause. Deficiency states can still exist even when serum cobalamin levels are higher than the traditional lower reference limit. Cobalamin-responsive elevations of serum methylmalonic acid (MMA) and homocysteine are helpful laboratory tools for the diagnosis. The health-related reference ranges for homocysteine and MMA appear to vary with age and gender.

Atrophic body gastritis is indirectly diagnosed by measuring serum levels of gastrin and pepsinogens, and it may cause dietary cobalamin malabsorption despite a normal traditional Schilling’s test. The use of gastroscopy may also be considered to diagnose dysplasia, bacterial overgrowth and intestinal villous atrophy in healthy patients with atrophic body gastritis or concomitant iron or folic acid deficiency. Elderly patients respond to cobalamin treatment as fully as younger patients, with complete haematological recovery and complete or good partial resolution of neurological deficits. Chronic dementia responds poorly but should, nevertheless, be treated if there is a metabolic deficiency (as indicated by elevated homocysteine and/or MMA levels).

Patients who are at risk from cobalamin deficiency include those with a gastrointestinal predisposition (e.g. atrophic body gastritis or previous partial gastrectomy), autoimmune disorders [type 1 (insulin-dependent) diabetes mellitus and thyroid disorders], those receiving long term therapy with gastric acid inhibitors or biguanides, and those undergoing nitrous oxide anaesthesia. To date, inadequate cobalamin intake has not proven to be a major risk factor. Intervention trials of cobalamin, folic acid and pyridoxine (vitamin B6) in unselected elderly populations are currently under way.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Henry FP, Osler W. Atrophy of the stomach with the clinical features of progressive pernicious anemia. Am J Med Sci 1886; 91: 498–511

    Google Scholar 

  2. Elsborg L, Nielsen JA, Bertram U, et al. The intake of vitamins and minerals by the elderly at home. Int J Vitam Nutr Res 1983; 53: 321–9

    PubMed  CAS  Google Scholar 

  3. Garry PJ, Goodwin JS, Hunt WC. Folate and vitamin B12 status in a healthy elderly population. J Am Geriatr Soc 1984; 32: 719–26

    PubMed  CAS  Google Scholar 

  4. Russell RM. Micronutrient requirements of the elderly. Nutr Rev 1992; 50: 463–6

    PubMed  CAS  Google Scholar 

  5. Russell RM, Suter PM. Vitamin requirements of elderly people: an update. Am J Clin Nutr 1993; 58: 4–14

    PubMed  CAS  Google Scholar 

  6. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693–8

    PubMed  CAS  Google Scholar 

  7. Stampfer MJ, Willett WC. Homocysteine and marginal vitamin deficiency: the importance of adequate vitamin intake. JAMA 1993; 270: 2726–7

    PubMed  CAS  Google Scholar 

  8. Strickland RG, Korman MG, Hansky J. Gastrin, age and the gastric mucosa. Aust J Med 1973; 3: 152–6

    CAS  Google Scholar 

  9. Glass GBJ, Pitchumoni CS. Atrophic gastritis. Hum Pathol 1975; 6: 219–50

    Google Scholar 

  10. Kekki M, Siurala M, Varis K, et al. Classification principles and genetics of chronic gastritis. Scand J Gastroenterol 1987; 22Suppl. 141: 1–28

    Google Scholar 

  11. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988; 83: 504–9

    PubMed  CAS  Google Scholar 

  12. Misiewicz JJ, Tytgat GNJ, Goodwin CS, et al. 9th World Congress of Gastroenterology, Sydney 1990, Working Party Report. Melbourne: Blackwell Scientific Publications, 1990: 1–10

    Google Scholar 

  13. Villako K, Kekki M, Maaroos HI, et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol 1991; 26Suppl. 186: 135–41

    Google Scholar 

  14. Kekki M, Samloff IM, Ihamäki T, et al. Age- and sex-related behaviour of gastric acid secretion at the population level. Scand J Gastroenterol 1982; 17: 737–43

    PubMed  CAS  Google Scholar 

  15. Kekki M, Varis K, Pohjanpalo H, et al. Course of antrum and body gastritis in pernicious anemia families. Dig Dis Sci 1983; 28: 698–704

    PubMed  CAS  Google Scholar 

  16. Varis O, Valle J, Siurala M. Is Helicobacter pylori involved in the pathogenesis of the gastritis characteristic of pernicious anaemia? Comparison between pernicious anaemia relatives and duodenal ulcer relatives. Scand J Gastroenterol 1993; 28: 705–8

    PubMed  CAS  Google Scholar 

  17. Rose MS, Chanarin I. Intrinsic-factor antibody and absorption of vitamin B12 in pernicious anaemia. BMJ 1971; 1: 25–6

    PubMed  CAS  Google Scholar 

  18. Bunting RW, Bitzer AM, Kenney RM, et al. Prevalence of intrinsic factor antibodies and vitamin B12 malabsorption in older patients admitted to a rehabilitation hospital. J Am Geriatr Soc 1990; 38: 743–7

    PubMed  CAS  Google Scholar 

  19. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol 1992; 89: 74–7

    PubMed  CAS  Google Scholar 

  20. Nilsson-Ehle H, Landahl S, Lindstedt G, et al. Low serum cobalamin levels in a population study of 70- and 75-year-old subjects: gastrointestinal causes and haematological effects. Dig Dis Sci 1989; 34: 716–23

    PubMed  CAS  Google Scholar 

  21. Burman P, Mårdh S, Norberg L, et al. Parietal cell antibodies in pernicious anemia inhibit H +, K +-adenosine triphosphatase, the proton pump of the stomach. Gastroenterology 1989; 96: 1434–8

    PubMed  CAS  Google Scholar 

  22. Irvine WJ, Davies SH, Delamore IW, et al. Immunological relationship between pernicious anaemia and thyroid disease. BMJ 1962; 2: 254–6

    Google Scholar 

  23. Davis RE, McCann VJ, Stanton KG. Type 1 diabetes and latent pernicious anaemia. Med J Aust 1992; 156: 160–2

    PubMed  CAS  Google Scholar 

  24. Ottesen M, Feldt Rasmussen U, Andersen J, et al. Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment. J Endocrinol Invest 1995; 18: 91–7

    PubMed  CAS  Google Scholar 

  25. Karnes WE, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167–74

    PubMed  Google Scholar 

  26. Fukao A, Komatsu S, Tsubono Y, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control 1993; 4: 307–12

    PubMed  CAS  Google Scholar 

  27. Sitas F, Smallwood R, Jewell D, et al. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1993; 2: 119–23

    PubMed  CAS  Google Scholar 

  28. Carmel R, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and food-cobalamin malabsorption. Dig Dis Sci 1994; 39: 309–14

    PubMed  CAS  Google Scholar 

  29. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525–8

    PubMed  CAS  Google Scholar 

  30. Negrini R, Savio A, Poiesi C, et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655–65

    PubMed  CAS  Google Scholar 

  31. McGuigan JE, Trudeau WL. Serum gastrin concentrations in pernicious anemia. N Engl J Med 1970; 282: 358–61

    PubMed  CAS  Google Scholar 

  32. Lewin KJ, Dowling F, Wright JP, et al. Gastric morphology and serum gastrin levels in pernicious anemia. Gut 1976; 17: 551–60

    PubMed  CAS  Google Scholar 

  33. Stockbruegger R, Angervall L, Lundqvist G. Serum gastrin and atrophic gastritis in achlorhydric patients with and without pernicious anemia. Scand J Gastroenterol 1976; 11: 713–9

    Google Scholar 

  34. Fahrenkrug J, Schaffalitzky de Muckadell OB, Hornum I, et al. The mechanism of hypergastrinemia in achlorhydria: effect of food, acid, and calcitonin on serum gastrin concentrations and component pattern in pernicious anemia, with correlation to endogenous secretin concentrations in plasma. Gastroenterology 1976; 71: 33–7

    PubMed  CAS  Google Scholar 

  35. Varis K, Samloff IM, Ihamäki T, et al. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci 1979; 24: 187–91

    PubMed  CAS  Google Scholar 

  36. Slingerland DW, Cardarelli JA, Burrows BA, et al. The utility of serum gastrin levels in assessing the significance of low serum B12 levels. Arch Intern Med 1984; 144: 1167–8

    PubMed  CAS  Google Scholar 

  37. Samloff IM, Varis K, Ihamäki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology. Gastroenterology 1982; 83: 204–9

    PubMed  CAS  Google Scholar 

  38. Peyre S, Di Napoli A, Pelissero A, et al. Diagnostic usefulness of serum group I pepsinogen determination. Gastroenterol Clin Biol 1983; 7: 793–8

    PubMed  CAS  Google Scholar 

  39. Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol 1988; 90: 442–5

    PubMed  CAS  Google Scholar 

  40. Borch K, Axelsson CK, Halgreen H, et al. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989; 24: 870–6

    PubMed  CAS  Google Scholar 

  41. Burman P, Karlsson FA, Loof L, et al. H +,K +-ATPase antibodies in autoimmune gastritis: observations on the development of pernicious anemia. Scand J Gastroenterol 1991; 26: 207–14

    PubMed  CAS  Google Scholar 

  42. Haruki K, Kurokawa K, Adachi H, et al. Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese. Gastroenterol Jpn 1993; 28: 359–66

    PubMed  CAS  Google Scholar 

  43. Nexo E, Hansen M, Rasmussen K, et al. How to diagnose cobalamin deficiency. Scand J Clin Lab Invest Suppl 1994; 219: 61–76

    PubMed  CAS  Google Scholar 

  44. Christiansen PM. The incidence of achlorhydria and hypochlorhydria in healthy subjects and patients with gastrointestinal diseases. Scand J Gastroenterol 1968; 3: 497–508

    PubMed  CAS  Google Scholar 

  45. Siurala M, Isokoski M, Varis K, et al. Prevalence of gastritis in a rural population. Scand J Gastroenterol 1968; 3: 211–23

    PubMed  CAS  Google Scholar 

  46. Villako K, Tamm A, Savisaar E, et al. Prevalence of antral and fundic atrophic gastritis in a randomly selected group of an Estonian rural population. Scand J Gastroenterol 1976; 11: 817–22

    PubMed  CAS  Google Scholar 

  47. Cheli R, Simohn L, Aste H, et al. Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations. Endoscopy 1980; 12: 105–8

    PubMed  CAS  Google Scholar 

  48. Ihamäki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families: comparison with a computer-matched family sample. Scand J Gastroenterol 1979; 11: 817–22

    Google Scholar 

  49. Krasinski SD, Russell RM, Samloff M, et al. Fundic atrophic gastritis in an elderly population. J Am Geriatr Soc 1986; 34: 800–6

    PubMed  CAS  Google Scholar 

  50. Potet F, Florent C, Benhamou E, et al. Chronic gastritis: prevalence in the French population. Gastroenterol Clin Biol 1993; 17: 103–8

    PubMed  CAS  Google Scholar 

  51. Feldman M, Cryer B, McArthur KE, et al. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 1996; 110: 1043–52

    PubMed  CAS  Google Scholar 

  52. Hurwitz A, Brady DA, Schaal SE, et al. Gastric acidity in older adults. JAMA 1997; 278: 659–62

    PubMed  CAS  Google Scholar 

  53. Chanarin I. Pernicious anaemia. In: The megaloblastic anaemias. Blackwell Scientific Publications, 1979: 316–31

    Google Scholar 

  54. Schilling RF, Madison W. Intrinsic factor studies. J Lab Clin Med 1953; 42: 860–6

    PubMed  CAS  Google Scholar 

  55. Nilsson-Ehle H, Jagenburg R, Landahl S, et al. Cyanocobalamin absorption in the elderly: results for healthy subjects and for subjects with low serum cobalamin concentration. Clin Chem 1986; 32: 1368–71

    PubMed  CAS  Google Scholar 

  56. Döscherholmen A, Swaim WR. Impaired assimilation of egg Co57-vitamin B12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology 1973; 64: 913–9

    PubMed  Google Scholar 

  57. Streeter AM, Shum H-Y, Duncombe VM, et al. Vitamin B12 malabsorption associated with a normal Schilling test result. Med J Aust 1976; 1: 54–5

    PubMed  CAS  Google Scholar 

  58. King CE, Leibach J, Toskes PP. Clinically significant vitamin B12 deficiency secondary to malabsorption of proteinbound vitamin B12. Dig Dis Sci 1979; 24: 397–402

    PubMed  CAS  Google Scholar 

  59. Carmel R, Sinow RM, Siegel ME, et al. Food cobalamin malabsorption occurs frequently in patients with unexplained low serum cobalamin levels. Arch Intern Med 1988; 148: 1715–9

    PubMed  CAS  Google Scholar 

  60. Jones BP, Broomhead AF, Kwan YL, et al. Incidence and clinical significance of protein-bound vitamin B12 malabsorption. Eur J Haematol 1987; 38: 131–6

    PubMed  CAS  Google Scholar 

  61. Carmel R, Sinow RM, Karnaze DS. Atypical cobalamin deficiency: subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with protein-bound cobalamin malabsorption. J Lab Clin Med 1987; 109: 454–63

    PubMed  CAS  Google Scholar 

  62. Carmel R. Reversal by cobalamin therapy of minimal defects in the deoxyuridine suppression test in patients without anemia: further evidence for a subtle metabolic cobalamin deficiency. J Lab Clin Med 1992; 119: 240–4

    PubMed  CAS  Google Scholar 

  63. Scarlett JD, Read H, O’Dea K. Protein-bound cobalamin absorption declines in the elderly. Am J Hematol 1992; 39: 79–83

    PubMed  CAS  Google Scholar 

  64. Joosten E, Pelemans W, Devos P, et al. Cobalamin absorption and serum homocysteine and methylmalonic acid in elderly subjects with low serum cobalamin. Eur J Haematol 1993; 51: 25–30

    PubMed  CAS  Google Scholar 

  65. Sherwood WC, Goldstein F, Haurani FI, et al. Studies of the small-intestinal bacterial flora and of intestinal absorption in pernicious anemia. Am J Dig Dis 1964; 9: 416–25

    PubMed  CAS  Google Scholar 

  66. Gianella RA, Brottman SA, Zamcheck N. Vitamin B12 uptake by intestinal microorganisms: mechanism and relevance to syndromes of intestinal bacterial overgrowth. J Clin Invest 1971; 50: 1100–7

    Google Scholar 

  67. Schjönsby H. The effect of bacteria on intestinal uptake of vitamin B12: I. Effect of cultures of blind-loop contents. Scand J Gastroenterol 1972; 7: 119–28

    PubMed  Google Scholar 

  68. Schjönsby H. The mechanism of vitamin B12 malabsorption in blind loop syndrome. Scand J Gastroenterol 1973; 8: 97–9

    PubMed  Google Scholar 

  69. Roberts SH, James O, Jarvis EH. Bacterial overgrowth syndrome without ‘blind loop’: a cause for malnutrition in the elderly. Lancet 1977; II: 1193–5

    Google Scholar 

  70. Suter PM, Golner BB, Goldin BR, et al. Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology 1991; 101: 1039–45

    PubMed  CAS  Google Scholar 

  71. Saltzman JR, Russell RM. Nutritional consequences of intestinal bacterial overgrowth. Compr Ther 1994; 20: 523–30

    PubMed  CAS  Google Scholar 

  72. Sipponen P, Kekki M, Siurala M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer 1984; 49: 521–30

    PubMed  CAS  Google Scholar 

  73. Witte S, Langer J, Stolte M. Uber die Häufigkeit und Bedeutung der Perniziosa-Schleimhautkonstellation im Magen. Z Gastroenterol 1986; 24: 353–6

    PubMed  CAS  Google Scholar 

  74. Hastrup Svendsen J, Dahl C, Svendsen LB, et al. Gastric cancer risk in achlorhydric patients. Scand J Gastroenterol 1986; 21: 16–20

    Google Scholar 

  75. Borch K. Epidemiologic, clinicopathologic and economic aspects of gastroscopic screening of patients with pernicious anaemia. Scand J Gastroenterol 1986; 21: 21–30

    PubMed  CAS  Google Scholar 

  76. Kokkola A, Haapiainen R, Laxen F, et al. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. J Clin Pathol 1996; 49: 979–84

    PubMed  CAS  Google Scholar 

  77. Carmel R, Weiner JM, Johnson CS. Iron deficiency occurs frequently in patients with pernicious anemia. JAMA 1987; 257: 1081–3

    PubMed  CAS  Google Scholar 

  78. Adams JF, Cartwright EJ. The reliability and reproducibility of the Schilling test in primary malabsorptive disease and after partial gastrectomy. Gut 1963; 4: 32–6

    PubMed  CAS  Google Scholar 

  79. Mahmud K, Ripley D, Döscherholmen A. Vitamin B12 absorption tests: their unreliability in postgastrectomy states. JAMA 1971; 216: 1167–71

    PubMed  CAS  Google Scholar 

  80. Rygvold O. Hypovitaminosis B12 following partial gastrectomy by the Billroth II method. Scand J Gastroenterol 1974; 9Suppl. 29: 57–64

    Google Scholar 

  81. Roos D. Neurological symptoms and signs in a selected group of partially gastrectomized patients with particular reference to B12 deficiency. Acta Neurol Scand 1974; 50: 719–52

    PubMed  CAS  Google Scholar 

  82. Sumner AE, Chin MM, Abrahm JL, et al. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery. Ann Intern Med 1996; 124: 469–76

    PubMed  CAS  Google Scholar 

  83. Toskes PP. Current concepts of cobalamin absorption and malabsorption. J Clin Gastroenterol 1980; 2: 287–97

    PubMed  CAS  Google Scholar 

  84. Gueant J-L, Champigneulle B, Gaucher P, et al. Malabsorption of vitamin B12 in pancreatic insufficiency of the adult and of the child. Pancreas 1990; 5: 559–67

    PubMed  CAS  Google Scholar 

  85. Webster SGP, Leeming JT. The appearance of the small bowel mucosa in old age. Age Ageing 1975; 4: 168–74

    PubMed  CAS  Google Scholar 

  86. Warren PM, Pepperman MA, Montgomery RD. Age changes in small intestinal mucosa. Lancet 1978; II: 849–50

    Google Scholar 

  87. Weiner R, Dietze F, Laue R. Age-dependent alterations of intestinal absorption: II. A clinical study using a modified D-xylose absorption test. Arch Gerontol Geriatr 1984; 3: 97–108

    PubMed  CAS  Google Scholar 

  88. Carmel R, Herbert V. Correctable intestinal defect of vitamin B12 absorption in pernicious anemia. Ann Intern Med 1967; 67: 1201–7

    PubMed  CAS  Google Scholar 

  89. Pena AS, Callender ST, Truelove SC, et al. Small intestinal mucosal abnormalities and disaccharidase activity in pernicious anaemia. Br J Haematol 1972; 23: 313–21

    PubMed  CAS  Google Scholar 

  90. Hankey GL, Holmes GK. Coeliac disease in the elderly. Gut 1994; 35: 65–7

    PubMed  CAS  Google Scholar 

  91. Hovdenak N. Coliaki hos eldre. Tidsskr Nor Laegeforen 1995; 115: 1491–3

    PubMed  CAS  Google Scholar 

  92. Midhagen G, Jarnerot G, Kraaz W. Adult coeliac disease within a defined geographic area in Sweden: a study of prevalence and associated diseases. Scand J Gastroenterol 1988; 23: 1000–4

    PubMed  CAS  Google Scholar 

  93. Talley NJ, Valdovinos M, Petterson TM, et al. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol 1994; 89: 843–6

    PubMed  CAS  Google Scholar 

  94. Kastrup W, Mobacken H, Stockbruegger R, et al. Malabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anaemia. Acta Med Scand 1986; 220: 261–8

    PubMed  CAS  Google Scholar 

  95. Mobacken H, Kastrup W, Nilsson LA. Incidence and prevalence of dermatitis herpetiformis in western Sweden. Acta Derm Venereol (Stockh) 1984; 64: 400–4

    CAS  Google Scholar 

  96. Festen HP. Prevention of duodenal ulcer relapse by long-term treatment with omeprazole. Scand J Gastroenterol Suppl 1994; 201: 39–41

    PubMed  CAS  Google Scholar 

  97. Steinberg W, King CE, Toskes PP. Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration. Dig Dis Sci 1980; 25: 188–92

    PubMed  CAS  Google Scholar 

  98. Salom IL, Silvis SE, Döscherholmen A. Effect of cimetidine on the absorption of vitamin B12. Scand J Gastroenterol 1982; 17: 129–31

    PubMed  CAS  Google Scholar 

  99. Belaiche J, Zittoun J, Marquet J, et al. Effet de la ranitidine sur la secretion de facteur intrinseque gastrique et sur l’absorption de la vitamine B12. Gastroenterol Clin Biol 1983; 7: 381–4

    PubMed  CAS  Google Scholar 

  100. Kittang E, Schjönsby H. Effect of gastric anacidity on the release of cobalamins from food and their subsequent binding to R-protein. Scand J Gastroenterol 1987; 22: 1031–7

    PubMed  CAS  Google Scholar 

  101. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med 1994; 120: 211–5

    PubMed  CAS  Google Scholar 

  102. Saltzman JR, Kemp JA, Golner BB, et al. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr 1994; 13: 584–91

    PubMed  CAS  Google Scholar 

  103. Festen HP. Intrinsic factor secretion and cobalamin absorption: physiology and pathophysiology in the gastrointestinal tract. Scand J Gastroenterol Suppl 1991; 188: 1–7

    PubMed  CAS  Google Scholar 

  104. Force RW, Nahata MC. Effect of histamine H2-receptor antagonists on vitamin B12 absorption. Ann Pharmacother 1992; 26: 1283–6

    PubMed  CAS  Google Scholar 

  105. Adams JF, Clark JS, Ireland JT, et al. Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy. Diabetologia 1983; 24: 16–8

    PubMed  CAS  Google Scholar 

  106. Salokannel SJ, Palva IP, Takkunen JT. Malabsorption of B12 during treatment with slow-release potassium chloride. Acta Med Scand 1970; 187: 431–2

    PubMed  CAS  Google Scholar 

  107. Flippo TS, Holder Jr WD. Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. Arch Surg 1993; 128: 1391–5

    PubMed  CAS  Google Scholar 

  108. Kinsella LJ, Green R. ‘Anesthesia paresthetica’: nitrous oxide-induced cobalamin deficiency. Neurology 1995; 45: 1608–10

    PubMed  CAS  Google Scholar 

  109. Carmel R, Rabinowitz AP, Mazumder A. Metabolic evidence of cobalamin deficiency in bone marrow cells harvested for transplantation from donors given nitrous oxide. Eur J Haematol 1993; 50: 228–33

    PubMed  CAS  Google Scholar 

  110. Rachmilewitz M, Izak G, Hochman A, et al. Serum vitamin B12 in leukemias and malignant lymphomas. Blood 1957; 12: 804–13

    PubMed  CAS  Google Scholar 

  111. Gimsing P, Overballe-Petersen C, Hippe E. Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia. Leukemia 1995; 9: 1604–9

    PubMed  CAS  Google Scholar 

  112. Fremont S, Champigneulle B, Gerard P, et al. Blood transcobalamin levels in malignant hepatoma. Tumour Biol 1991; 12: 353–9

    PubMed  CAS  Google Scholar 

  113. Gimsing P, Nexo E. Cobalamin-binding capacity of haptocorrin and transcobalamin: age-correlated reference intervals and values from patients. Clin Chem 1989; 35: 1447–51

    PubMed  CAS  Google Scholar 

  114. Herzlich B, Herbert V. Depletion of serum holotranscobalamin II: an early sign of negative vitamin B12 balance. Lab Invest 1988; 58: 332–7

    PubMed  CAS  Google Scholar 

  115. Herbert V. Don’t ignore low serum vitamin B12 levels. Arch Intern Med 1988; 148: 1705–7

    PubMed  CAS  Google Scholar 

  116. Wickramasinghe SN, Fida S. Correlations between holotranscobalamin II, holo-haptocorrin, and total B12 in serum samples from healthy subjects and patients. J Clin Pathol 1993; 46: 537–9

    PubMed  CAS  Google Scholar 

  117. Metz J, Bell AH, Flicker L, et al. The significance of subnormal serum vitamin B12 concentration in older people: a case control study. J Am Geriatr Soc 1996; 44: 1355–61

    PubMed  CAS  Google Scholar 

  118. Solberg HE. The theory of reference values. J Clin Chem Clin Biochem 1983; 21: 749–60

    PubMed  CAS  Google Scholar 

  119. Nilsson-Ehle H, Jagenburg R, Landahl S, et al. Serum cobalamins in the elderly: a longitudinal study of a representative population sample from age 70 to 81. Eur J Haematol 1991; 47: 10–6

    PubMed  CAS  Google Scholar 

  120. Nexö E. Variation with age of reference values for P-cobalamins. Scand J Haematol 1983; 30: 430–2

    PubMed  Google Scholar 

  121. Magnus EM, Bache-Wiig JE, Anderson TR, et al. Folate and vitamin B12 blood levels in elderly persons in geriatric homes. Scand J Haematol 1982; 28: 360–6

    PubMed  CAS  Google Scholar 

  122. Hayes AN, Willans DJ, Skelton D. Vitamin B12 and folate blood levels in a geriatric reference group as measured by two kits. Clin Biochem 1985; 18: 56–61

    PubMed  CAS  Google Scholar 

  123. Hitzhusen JC, Taplin ME, Stephenson WP, et al. Vitamin B12 levels and age. Am J Clin Pathol 1986; 85: 32–6

    PubMed  CAS  Google Scholar 

  124. Barber KE, Christie ML, Thula R, et al. Vitamin B12 concentrations in the elderly: a regional study. N Z J Med 1989; 102: 406–8

    Google Scholar 

  125. Joosten E, Pelemans W, Hiele M, et al. Vitamin B12 (cobalamin)-deficiency in the elderly [in Dutch]. Ned Tijdschr Geneeskd 1990; 134: 652–6

    PubMed  CAS  Google Scholar 

  126. Haller J, Lowik MR, Ferry M, et al., Euronut SENECA investigators. Nutritional status: blood vitamins A, E, B6, B12, folic acid and carotene. Eur J Clin Nutr 1991; 45Suppl. 3: 63–82

    PubMed  Google Scholar 

  127. Hanger HC, Sainsbury R, Gilchrist NL, et al. A community study of vitamin B12 and folate levels in the elderly. J Am Geriatr Soc 1991; 39: 1155–9

    PubMed  CAS  Google Scholar 

  128. Matthews JH, Clark DM, Abrahamson GM. Effect of therapy with vitamin B12 and folic acid on elderly patients with low concentrations of serum vitamin B12 or erythrocyte folate but normal blood counts. Acta Haematol 1988; 79: 84–7

    PubMed  CAS  Google Scholar 

  129. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720–8

    PubMed  CAS  Google Scholar 

  130. Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr 1992; 55Suppl. 6: 1203S–7S

    PubMed  CAS  Google Scholar 

  131. Yao Y, Yao SL, Yao SS, et al. Prevalence of vitamin B12 deficiency among geriatric outpatients. J Fam Pract 1992; 35: 524–8

    PubMed  CAS  Google Scholar 

  132. Healton EB, Savage DG, Brust JC, et al. Neurologic aspects of cobalamin deficiency. Med Baltimore 1991; 70: 229–45

    CAS  Google Scholar 

  133. Skoog I, Nilsson L, Palmertz B, et al. A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328: 153–8

    PubMed  CAS  Google Scholar 

  134. Wahlin A, Hill RD, Winblad B, et al. Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: a population-based study. Psychol Aging 1996; 11: 487–96

    PubMed  CAS  Google Scholar 

  135. Regland B, Gottfries CG, Lindstedt G. Dementia patients with low serum cobalamin concentration: relationship to atrophic gastritis. Aging Milano 1992; 4: 35–41

    PubMed  CAS  Google Scholar 

  136. Teunisse S, Bollen AE, van Gool WA, et al. Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia. J Neurol 1996; 243: 522–9

    PubMed  CAS  Google Scholar 

  137. Kristensen MO, Gulmann NC, Christensen JE, et al. Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand 1993; 87: 475–81

    PubMed  CAS  Google Scholar 

  138. Carmel R, Gott PS, Waters CH, et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol 1995; 54: 245–53

    PubMed  CAS  Google Scholar 

  139. Bell IR, Edman JS, Selhub J, et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992; 86: 386–90

    PubMed  CAS  Google Scholar 

  140. Verhoef P, Hennekens CH, Malinow MR, et al. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 1994; 25: 1924–30

    PubMed  CAS  Google Scholar 

  141. Guba SC, Fink LM, Fonseca V. Hyperhomocysteinemia: an emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol 1996; 106: 709–22

    PubMed  CAS  Google Scholar 

  142. Herzlich BC, Lichstein E, Schulhoff N, et al. Relationship among homocysteine, vitamin B-12 and cardiac disease in the elderly: association between vitamin B-12 deficiency and decreased left ventricular ejection fraction. J Nutr 1996; 126Suppl. 4: 1249S–53S

    PubMed  CAS  Google Scholar 

  143. Malinow MR. Plasma homocysteine: a risk factor for arterial occlusive diseases. J Nutr 1996; 126Suppl. 4: 1238S–43S

    PubMed  CAS  Google Scholar 

  144. Lussier Cacan S, Xhignesse M, Piolot A, et al. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996; 64: 587–93

    PubMed  CAS  Google Scholar 

  145. Brattstrom L, Lindgren A, Israelsson B, et al. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236: 633–41

    PubMed  CAS  Google Scholar 

  146. Rasmussen K, Moller J, Lyngbak M, et al. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996; 42: 630–6

    PubMed  CAS  Google Scholar 

  147. Joosten E, Lesaffre E, Riezler R. Are different reference intervals for methylmalonic acid and total homocysteine necessary in elderly people? Eur J Haematol 1996; 57: 222–6

    PubMed  CAS  Google Scholar 

  148. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764–79

    PubMed  CAS  Google Scholar 

  149. Meleady RA, Graham IM. Homocysteine as a risk factor for coronary artery disease. J Cardiovasc Risk 1995; 2: 216–21

    PubMed  CAS  Google Scholar 

  150. Nilsson K, Gustafson L, Faldt R, et al. Hyperhomocysteinaemia — a common finding in a psychogeriatric population. Eur J Clin Invest 1996; 26: 853–9

    PubMed  CAS  Google Scholar 

  151. Riggs KM, Spiro III A, Tucker K, et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996; 63: 306–14

    PubMed  CAS  Google Scholar 

  152. Lindenbaum J, Savage DG, Stabler SP, et al. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990; 34: 99–107

    PubMed  CAS  Google Scholar 

  153. Savage DG, Lindenbaum J, Stabler SP, et al. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239–46

    PubMed  CAS  Google Scholar 

  154. Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr 1996; 126Suppl. 4: 1266S–72S

    PubMed  CAS  Google Scholar 

  155. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992; 40: 1197–204

    PubMed  CAS  Google Scholar 

  156. Joosten E, van den Berg A, Riezler R, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993; 58: 468–76

    PubMed  CAS  Google Scholar 

  157. Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60: 2–11

    PubMed  CAS  Google Scholar 

  158. Naurath HJ, Joosten E, Riezler R, et al. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995; 346: 85–9

    PubMed  CAS  Google Scholar 

  159. Koehler KM, Romero LJ, Stauber PM, et al. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 1996; 15: 364–76

    PubMed  CAS  Google Scholar 

  160. Chanarin I, Metz J. Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol 1997; 97: 695–700

    PubMed  CAS  Google Scholar 

  161. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology 1995; 45: 1435–40

    PubMed  CAS  Google Scholar 

  162. Swain R. An update of vitamin B12 metabolism and deficiency states. J Fam Pract 1995; 41: 595–600

    PubMed  CAS  Google Scholar 

  163. Carmel R. Treatment of severe pernicious anemia: no association with sudden death. Am J Clin Nutr 1988; 48: 1443–4

    PubMed  CAS  Google Scholar 

  164. Regland B, Abrahamsson L, Blennow K, et al. Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men. Acta Neurol Scand 1992; 85: 276–81

    PubMed  CAS  Google Scholar 

  165. Regland B, Andersson M, Abrahamsson L, et al. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol 1997; 26: 301–7

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Hematology, Department of Medicine, Sahlgrenska University Hospital/Östra, S-416 85, Göteborg, Sweden

    Herman Nilsson-Ehle

Authors
  1. Herman Nilsson-Ehle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson-Ehle, H. Age-Related Changes in Cobalamin (Vitamin B12) Handling. Drugs Aging 12, 277–292 (1998). https://doi.org/10.2165/00002512-199812040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199812040-00003

Keywords

Search

Navigation